Free tool
Stocks listed on Nasdaq GS
We cover 13 companies listed on Nasdaq GS. The median market value in the group is $71.05M. Across the group, the median move over the past trading day is −0.81%. Price change over the past year runs from −79.3% to −10.7% across the middle 80 percent of the group, with a median of −43.4%.
Other lists in this group
Table
13 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% | Nov 12, 2026 |
| CVRX | CVRx, Inc. | $87.12M | Micro cap | −56.75% | Nov 5, 2026 |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% | Nov 4, 2026 |
| DH | Definitive Healthcare Corp. | $84.34M | Micro cap | −80.44% | Nov 5, 2026 |
| OM | Outset Medical, Inc. | $79.89M | Micro cap | −69.56% | Nov 9, 2026 |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% | Nov 5, 2026 |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% | Nov 12, 2026 |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% | Nov 16, 2026 |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% | Nov 4, 2026 |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% | Nov 3, 2026 |
| PETS | PetMed Express, Inc. | $38.81M | Micro cap | −43.35% | Nov 16, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% | Nov 9, 2026 |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.